Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke

被引：1
|
作者：
Kirshner, Howard S. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37232 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2012年 / 18卷 / 33期
关键词：
Ischemic stroke; secondary stroke prevention; antiplatelet therapy; PERCUTANEOUS CORONARY INTERVENTION; ARTERIAL ORIGIN ESPRIT; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; CEREBRAL-ISCHEMIA; PLATELET-FUNCTION; CYP2C19; GENOTYPE; 1ST-EVER STROKE; BLOOD-PRESSURE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Stroke prevention is highly effective but underutilized in medical care. Lifestyle modification, in the form of diet, exercise, smoking cessation, antihypertensive therapy, close control of diabetes and hyperlipidemia, can prevent most strokes. Selected subgroups can benefit from carotid surgery or stenting, anticoagulation for atrial fibrillation, and antiplatelet therapy. Evidence for these approaches and alternative management strategies are discussed.
引用
收藏
页码：5261 / 5272
页数：12
相关论文
共 50 条
  • [21] Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications
    Su, Ya
    Cheng, Xin
    Dong, Qiang
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (11) : 870 - 876
  • [22] Antiplatelet Strategies for Secondary Prevention of Stroke and TIA
    Koto Ishida
    Steven R. Messé
    Current Atherosclerosis Reports, 2014, 16
  • [23] Differentiating ischemic stroke subtypes: Risk factors and secondary prevention
    Kirshner, Howard S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279 (1-2) : 1 - 8
  • [24] Current status of antiplatelet treatment before and after ischemic stroke, and an analysis of factors associated with antiplatelet treatment, in the Qingdao area of China
    Wang Xin
    Wang Ping
    Yu Tan-fang
    Zhang Min
    Du Zheng-qiang
    Xing Cheng-ming
    CHINESE MEDICAL JOURNAL, 2011, 124 (24) : 4254 - 4259
  • [25] Antiplatelet Use in Ischemic Stroke
    Kamarova, Marharyta
    Baig, Sheharyar
    Patel, Hamish
    Monks, Kimberley
    Wasay, Mohammed
    Ali, Ali
    Redgrave, Jessica
    Majid, Arshad
    Bell, Simon M.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (10) : 1159 - 1173
  • [26] Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack
    Scalia, Lorenzo
    Calderone, Dario
    Capodanno, Davide
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (09) : 1027 - 1038
  • [27] Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: Case report and review of the literature
    Patterson, Shawnna L.
    LaMonte, Marian P.
    Mikdashi, Jamal A.
    Haines, Stuart T.
    Hursting, Marcie J.
    PHARMACOTHERAPY, 2006, 26 (10): : 1518 - 1525
  • [28] Antiplatelet Therapy in Stroke Prevention
    Apostolakis, Stavros
    Marin, Francisco
    Lip, Gregory Y. H.
    ANTIPLATELET THERAPY IN ACS AND A-FIB, 2012, 47 : 141 - 154
  • [29] Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
    Pezzella, Francesca Romana
    Mangiardi, Marilena
    Ferrante, Mario
    Fabiano, Sebastiano
    Anticoli, Sabrina
    Pennacchi, Fabrizio Giorgio
    Urso, Antonella
    De Luca, Leonardo
    Caso, Valeria
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [30] Antiplatelet agents for stroke prevention following transient ischemic attack
    Weinberger, Jesse
    SOUTHERN MEDICAL JOURNAL, 2008, 101 (01) : 70 - 78
12345